Literature DB >> 11565551

Non-invasive evaluation of arterial involvement in patients affected with Fabry disease.

P Boutouyrie, S Laurent, B Laloux, O Lidove, J P Grunfeld, D P Germain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11565551      PMCID： PMC1734931          DOI： 10.1136/jmg.38.9.629

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  9 in total

1.  Structural and functional changes in peripheral vasculature of Fabry patients.

Authors:  Riikka J Kalliokoski; Kari K Kalliokoski; Maila Penttinen; Ilkka Kantola; Aila Leino; Jorma S Viikari; Olli Simell; Pirjo Nuutila; Olli T Raitakari
Journal:  J Inherit Metab Dis       Date:  2006-08-12       Impact factor: 4.982

2.  Imbalanced Production of Reactive Oxygen Species and Mitochondrial Antioxidant SOD2 in Fabry Disease-Specific Human Induced Pluripotent Stem Cell-Differentiated Vascular Endothelial Cells.

Authors:  Wei-Lien Tseng; Shih-Jie Chou; Huai-Chih Chiang; Mong-Lien Wang; Chian-Shiu Chien; Kuan-Hsuan Chen; Hsin-Bang Leu; Chien-Ying Wang; Yuh-Lih Chang; Yung-Yang Liu; Yuh-Jyh Jong; Shinn-Zong Lin; Shih-Hwa Chiou; Shing-Jong Lin; Wen-Chung Yu
Journal:  Cell Transplant       Date:  2016-12-06       Impact factor: 4.064

3.  Intravascular ultrasound assessment of coronary artery involvement in Fabry disease.

Authors:  T Kovarnik; G S Mintz; D Karetova; J Horak; J Bultas; R Skulec; H Skalicka; M Aschermann; M Elleder; A Linhart
Journal:  J Inherit Metab Dis       Date:  2008-11-08       Impact factor: 4.982

4.  Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment.

Authors:  T Heare; N J Alp; D A Priestman; A B Kulkarni; P Qasba; T D Butters; R A Dwek; K Clarke; K M Channon; F M Platt
Journal:  J Inherit Metab Dis       Date:  2006-12-25       Impact factor: 4.982

Review 5.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

6.  Arterial wall properties and Womersley flow in Fabry disease.

Authors:  David F Moore; Gheona Altarescu; Randall Pursley; Umberto Campia; Julio A Panza; Emilios Dimitriadis; Raphael Schiffmann
Journal:  BMC Cardiovasc Disord       Date:  2002-01-10       Impact factor: 2.298

7.  Bridging the Gap Between Vessels and Nerves in Fabry Disease.

Authors:  Julia Forstenpointner; Manon Sendel; Paul Moeller; Maren Reimer; Sima Canaan-Kühl; Jens Gaedeke; Stefanie Rehm; Philipp Hüllemann; Janne Gierthmühlen; Ralf Baron
Journal:  Front Neurosci       Date:  2020-06-16       Impact factor: 4.677

8.  Voluntary wheel running activates Akt/AMPK/eNOS signaling cascades without improving profound endothelial dysfunction in mice deficient in α-galactosidase A.

Authors:  Justin J Kang; Taylour A Treadwell; Peter F Bodary; James A Shayman
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

Review 9.  Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective.

Authors:  Fatih Ezgu; Erkan Alpsoy; Zerrin Bicik Bahcebasi; Ozgur Kasapcopur; Melis Palamar; Huseyin Onay; Binnaz Handan Ozdemir; Mehmet Akif Topcuoglu; Omac Tufekcioglu
Journal:  Orphanet J Rare Dis       Date:  2022-03-02       Impact factor: 4.123
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.